Relative Bioavailability and Food Effect Study of an Oral Suspension of Alectinib in Healthy Volunteers Using Venipuncture and Capillary Microsampling.
Sign Up to like & getrecommendations! Published in 2023 at "Clinical and translational science"
DOI: 10.1111/cts.13515
Abstract: Alectinib, approved as 150 mg capsules for the treatment of adults with advanced ALK-positive non-small-cell lung cancer, is being assessed in children with ALK-positive solid and central nervous system tumors. An ad hoc pediatric-friendly suspension… read more here.
Keywords: relative bioavailability; suspension alectinib; capsule; suspension ... See more keywords